G Modinos1, P Allen1, M Frascarelli1, S Tognin1, L Valmaggia1, L Xenaki1, P Keedwell2, M Broome3, I Valli1, J Woolley1, J M Stone1, A Mechelli1, M L Phillips4, P McGuire1, P Fusar-Poli1. 1. Department of Psychosis Studies, Institute of Psychiatry,King's College London,London,UK. 2. Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics,Cardiff University,Cardiff,UK. 3. Department of Psychiatry,University of Oxford,Oxford,UK. 4. Department of Psychiatry, Western Psychiatric Institute and Clinic,University of Pittsburgh,Pittsburgh, PA,USA.
Abstract
BACKGROUND: The majority of people at ultra high risk (UHR) of psychosis also present with co-morbid affective disorders such as depression or anxiety. The neuroanatomical and clinical impact of UHR co-morbidity is unknown. METHOD: We investigated group differences in grey matter volume using baseline magnetic resonance images from 121 participants in four groups: UHR with depressive or anxiety co-morbidity; UHR alone; major depressive disorder; and healthy controls. The impact of grey matter volume on baseline and longitudinal clinical/functional data was assessed with regression analyses. RESULTS: The UHR-co-morbidity group had lower grey matter volume in the anterior cingulate cortex than the UHR-alone group, with an intermediate effect between controls and patients with major depressive disorder. In the UHR-co-morbidity group, baseline anterior cingulate volume was negatively correlated with baseline suicidality/self-harm and obsessive-compulsive disorder symptoms. CONCLUSIONS: Co-morbid depression and anxiety disorders contributed distinctive grey matter volume reductions of the anterior cingulate cortex in people at UHR of psychosis. These volumetric deficits were correlated with baseline measures of depression and anxiety, suggesting that co-morbid depressive and anxiety diagnoses should be carefully considered in future clinical and imaging studies of the psychosis high-risk state.
BACKGROUND: The majority of people at ultra high risk (UHR) of psychosis also present with co-morbid affective disorders such as depression or anxiety. The neuroanatomical and clinical impact of UHR co-morbidity is unknown. METHOD: We investigated group differences in grey matter volume using baseline magnetic resonance images from 121 participants in four groups: UHR with depressive or anxiety co-morbidity; UHR alone; major depressive disorder; and healthy controls. The impact of grey matter volume on baseline and longitudinal clinical/functional data was assessed with regression analyses. RESULTS: The UHR-co-morbidity group had lower grey matter volume in the anterior cingulate cortex than the UHR-alone group, with an intermediate effect between controls and patients with major depressive disorder. In the UHR-co-morbidity group, baseline anterior cingulate volume was negatively correlated with baseline suicidality/self-harm and obsessive-compulsive disorder symptoms. CONCLUSIONS: Co-morbid depression and anxiety disorders contributed distinctive grey matter volume reductions of the anterior cingulate cortex in people at UHR of psychosis. These volumetric deficits were correlated with baseline measures of depression and anxiety, suggesting that co-morbid depressive and anxiety diagnoses should be carefully considered in future clinical and imaging studies of the psychosis high-risk state.
Authors: Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods Journal: Schizophr Bull Date: 2015-09 Impact factor: 9.306
Authors: Paul Klauser; Juan Zhou; Joseph K W Lim; Joann S Poh; Hui Zheng; Han Ying Tng; Ranga Krishnan; Jimmy Lee; Richard S E Keefe; R Alison Adcock; Stephen J Wood; Alex Fornito; Michael W L Chee Journal: Schizophr Bull Date: 2015-03-04 Impact factor: 9.306
Authors: Laura Pina-Camacho; Ángel Del Rey-Mejías; Joost Janssen; Miquel Bioque; Ana González-Pinto; Celso Arango; Antonio Lobo; Salvador Sarró; Manuel Desco; Julio Sanjuan; Maria Lacalle-Aurioles; Manuel J Cuesta; Jerónimo Saiz-Ruiz; Miguel Bernardo; Mara Parellada Journal: Schizophr Bull Date: 2015-09-14 Impact factor: 9.306
Authors: Kristin M Healey; David L Penn; Diana Perkins; Scott W Woods; Richard S E Keefe; Jean Addington Journal: Schizophr Bull Date: 2018-02-15 Impact factor: 9.306
Authors: Scott W Woods; Albert R Powers; Jerome H Taylor; Charlie A Davidson; Jason K Johannesen; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan Journal: Schizophr Bull Date: 2018-02-15 Impact factor: 9.306
Authors: Mélodie Derome; Eduardo Fonseca-Pedrero; Deborah Badoud; Larisa Morosan; Dimitri Van De Ville; François Lazeyras; Stephan Eliez; Raymond Chan; David Rudrauf; Sophie Schwartz; Martin Debbane Journal: Schizophr Bull Date: 2018-10-15 Impact factor: 9.306
Authors: André Schmidt; Vaibhav A Diwadkar; Renata Smieskova; Fabienne Harrisberger; Undine E Lang; Philip McGuire; Paolo Fusar-Poli; Stefan Borgwardt Journal: Front Hum Neurosci Date: 2015-01-13 Impact factor: 3.169
Authors: Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold Journal: J Psychiatr Brain Sci Date: 2021-06-29